Core Viewpoint - Health元药业 Group has decided to extend the duration of its first phase of the long-term partner stockholding plan by 12 months until August 3, 2026, and to change the management method to self-management [1][8][12]. Group 1: Meeting and Resolutions - The 11th meeting of the 9th Board of Directors was held on July 25, 2025, where all nine directors participated, and the resolutions were passed without any objections [1][3]. - The first resolution approved was to extend the duration of the first phase of the stockholding plan by 12 months, allowing for early termination if all shares are sold before the new deadline [1][11]. - The second resolution approved was to change the management of the stockholding plan from Guosen Securities to self-management by the company [4][12]. Group 2: Voting Results - The voting results for the extension of the stockholding plan showed 6 votes in favor, with no votes against or abstentions [3][5]. - The second meeting of the stockholding plan holders also confirmed the extension with 100% approval from the participating holders [13][14]. Group 3: Background and Implementation - The first phase of the stockholding plan was initially approved at the second extraordinary general meeting of shareholders in 2021, with the plan's shares locked for 36 months from August 4, 2021, to August 3, 2024 [9][10]. - As of February 6, 2025, the plan held 2,430,800 shares, representing 0.13% of the company's total share capital [10].